Melanoma biology and new targeted therapy

Gray-Schopfer, Vanessa; Wellbrock, Claudia; Marais, Richard
February 2007
Nature;2/22/2007, Vol. 445 Issue 7130, p851
Academic Journal
Melanoma is a cancer that arises from melanocytes, specialized pigmented cells that are found predominantly in the skin. The incidence of melanoma is rising steadily in western populations — the number of cases worldwide has doubled in the past 20 years. In its early stages malignant melanoma can be cured by surgical resection, but once it has progressed to the metastatic stage it is extremely difficult to treat and does not respond to current therapies. Recent discoveries in cell signalling have provided greater understanding of the biology that underlies melanoma, and these advances are being exploited to provide targeted drugs and new therapeutic approaches.


Related Articles

  • Macular and Patch Lesions of Malignant Melanoma: Malignant Melanoma in situ. Ackerman, A. Bernard // Journal of Dermatologic Surgery & Oncology;Aug83, Vol. 9 Issue 8, p615 

    In order to speak about macular and patch lesions of malignant melanoma, that is malignant melanoma in situ, one must have clinical and histological criteria for the diagnosis of malignant melanomas and their differentiation from melanocytic nevi of various kinds. Those criteria are different at...

  • Elderly man with rapidly enlarging axillary mass. REID, C. M.; SWEET III, P. // European Review for Medical & Pharmacological Sciences;May2013, Vol. 17 Issue 10, p1334 

    Melanoma has long been known to be a malignancy that can present in a plethora of forms. This often makes diagnosing it a challenge, but lends support to the concept of frequently keeping it in the clinician's differential. We present the unique case of a rapidly enlarging axillary mass in an...

  • Kita Driven Expression of Oncogenic HRAS Leads to Early Onset and Highly Penetrant Melanoma in Zebrafish. Santoriello, Cristina; Gennaro, Elisa; Anelli, Viviana; Distel, Martin; Kelly, Amanda; Köster, Reinhard W.; Hurlstone, Adam; Mione, Marina // PLoS ONE;2010, Vol. 5 Issue 12, p1 

    Background: Melanoma is the most aggressive and lethal form of skin cancer. Because of the increasing incidence and high lethality of melanoma, animal models for continuously observing melanoma formation and progression as well as for testing pharmacological agents are needed. Methodology and...

  • Five Gene Locations Emerge as Strong Markers of Susceptibility for Melanoma.  // JNCI: Journal of the National Cancer Institute;Jul2011, Vol. 103 Issue 14, pNP 

    The article presents the results of an analysis of various studies on the association of genetic locations with the risk of melanoma skin cancer. It cites the collaborative project spearheaded by Alexander J. Stratigos and colleagues of the University of Athens Medical School in Greece which...

  • The Cancer Your Doctor May Miss. Mooney, Linda // Prevention;May99, Vol. 51 Issue 5, p132 

    Considers how melanoma is one of the most visible cancers, yet it is often overlooked. Importance of seeing a dermatologist; Risk factors; Need for regular self-checks; Melanoma prevention checklist; Where to get free skin exams.

  • In This Issue... Marx, Jean L. // Journal of Investigative Dermatology;Apr89, Vol. 92 Issue 4, p559 

    The fact that malignant melanomas can appear on skin that is rarely or never exposed to sunlight has been something of a puzzle in view of the large body of evidence suggesting that ultraviolet B (UVB) radiation is a major cause of skin cancer. In the April 1, 1989 issue of the "Journal of...

  • Cancer incidence and mortality in Spain: estimates and projections for the period 1981–2012. Sánchez, M. J.; Payer, T.; De Angelis, R.; Larrañaga, N.; Capocaccia, R.; Martinez, C. // Annals of Oncology;May2010, Vol. 21 Issue suppl_3, piii30 

    Background: National indicators of cancer burden are essential information for cancer surveillance and health planning, so that in countries with partial registration coverage and geographically variable risk patterns, such as Spain, this is even more relevant. This article provides estimates of...

  • Topical CuradermBEC5 Therapy for Periocular Nonmelanoma Skin Cancers: A Review of Clinical Outcomes. Cham, Bill E. // International Journal of Clinical Medicine;May2013, Vol. 4 Issue 5, p233 

    Approximately 5 to 10 percent of all skin cancers occur in the periocular region. Basal cell carcinoma is the most frequent malignant periocular tumor, followed by squamous cell carcinoma, sebaceous gland carcinoma, and malignant melanoma. Nonmelanoma skin tumors at the periocular area often...

  • Deaths from non-melanoma skin cancer in Western Australia. J. Girschik; Lin Fritschi; T. Threlfall // Cancer Causes & Control;Oct2008, Vol. 19 Issue 8, p879 

    Abstract Objectives  Non-melanoma skin cancer (NMSC) is common, slow growing, and rarely metastasizes. However, there are still nearly 400 deaths from NMSC in Australia annually. We aimed to investigate the accuracy of NMSC death coding and to describe the characteristics of these deaths...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics